Literature DB >> 16861106

Hippocampal FGF-2 and FGFR1 mRNA expression in major depression, schizophrenia and bipolar disorder.

Fiona Gaughran1, Joachim Payne, Philip M Sedgwick, David Cotter, Martin Berry.   

Abstract

INTRODUCTION: FGF-2 is important for stem cell proliferation, neocortical development and adult neuronal survival and growth. Reduced frontal cortical FGF-2 expression is described in major depression and is attenuated by antidepressants. We determined the distribution of hippocampal FGF-2 and its receptor (FGFR1) mRNA in post-mortem brains of people who suffered from major depression, bipolar disorder and schizophrenia and those of controls.
METHODS: FGF-2 and FGFR1 mRNA were measured within hippocampal CA1, CA4 regions and the dentate gyrus (DG), using in situ hybridization. Within hippocampal regions, cellular staining was compared between diagnostic groups, using repeated measures analysis of variance.
RESULTS: The density of FGF-2 mRNA+ cells in CA4 was reduced in depression compared to controls. The percentage of FGFR1 mRNA+ cells was higher in depression (CA1 and CA4) and schizophrenia (CA4) than in controls. FGFR1 mRNA expression was higher in depression than in the other groups in CA1, CA4 and DG. Overall FGF-2 mRNA expression was higher in DG than in CA1 and CA4.
CONCLUSIONS: We found raised measures of FGFR1 mRNA+ in major depression and, less so, in schizophrenia, along with reduced FGF-2 mRNA density in depression. Perturbations of FGF regulation could be relevant to the pathogenesis of both disorders as FGF-2 and FGFR1 are implicated in normal hippocampal synaptology, stem cell recruitment, and connectivity, and are modulated by corticosteroids.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16861106     DOI: 10.1016/j.brainresbull.2006.04.008

Source DB:  PubMed          Journal:  Brain Res Bull        ISSN: 0361-9230            Impact factor:   4.077


  70 in total

1.  Tricyclic antidepressant amitriptyline activates fibroblast growth factor receptor signaling in glial cells: involvement in glial cell line-derived neurotrophic factor production.

Authors:  Kazue Hisaoka; Mami Tsuchioka; Ryoya Yano; Natsuko Maeda; Naoto Kajitani; Norimitsu Morioka; Yoshihiro Nakata; Minoru Takebayashi
Journal:  J Biol Chem       Date:  2011-04-22       Impact factor: 5.157

2.  Fibroblast growth factor-2 (FGF2) augmentation early in life alters hippocampal development and rescues the anxiety phenotype in vulnerable animals.

Authors:  Cortney A Turner; Sarah M Clinton; Robert C Thompson; Stanley J Watson; Huda Akil
Journal:  Proc Natl Acad Sci U S A       Date:  2011-04-25       Impact factor: 11.205

Review 3.  Fibroblast growth factors in schizophrenia.

Authors:  Afke F Terwisscha van Scheltinga; Steven C Bakker; René S Kahn
Journal:  Schizophr Bull       Date:  2009-05-08       Impact factor: 9.306

4.  Neurotrophic paths in the treatment of depression.

Authors:  Shawn Hayley; Hymie Anisman
Journal:  J Psychiatry Neurosci       Date:  2013-09       Impact factor: 6.186

Review 5.  Functional biomarkers of depression: diagnosis, treatment, and pathophysiology.

Authors:  Heath D Schmidt; Richard C Shelton; Ronald S Duman
Journal:  Neuropsychopharmacology       Date:  2011-08-03       Impact factor: 7.853

6.  Differential activation of immune/inflammatory response-related co-expression modules in the hippocampus across the major psychiatric disorders.

Authors:  S Kim; Y Hwang; M J Webster; D Lee
Journal:  Mol Psychiatry       Date:  2015-06-16       Impact factor: 15.992

7.  A Novel Relationship for Schizophrenia, Bipolar, and Major Depressive Disorder. Part 8: a Hint from Chromosome 8 High Density Association Screen.

Authors:  Xing Chen; Feng Long; Bin Cai; Xiaohong Chen; Lizeng Qin; Gang Chen
Journal:  Mol Neurobiol       Date:  2016-09-22       Impact factor: 5.590

8.  Altered expression of genes involved in inflammation and apoptosis in frontal cortex in major depression.

Authors:  R C Shelton; J Claiborne; M Sidoryk-Wegrzynowicz; R Reddy; M Aschner; D A Lewis; K Mirnics
Journal:  Mol Psychiatry       Date:  2010-05-18       Impact factor: 15.992

9.  Neural stem cell regulation, fibroblast growth factors, and the developmental origins of neuropsychiatric disorders.

Authors:  Hanna E Stevens; Karen M Smith; Brian G Rash; Flora M Vaccarino
Journal:  Front Neurosci       Date:  2010-09-01       Impact factor: 4.677

10.  Molecular genetic analysis of FGFR1 signalling reveals distinct roles of MAPK and PLCgamma1 activation for self-renewal of adult neural stem cells.

Authors:  Dengke K Ma; Karthikeyan Ponnusamy; Mi-Ryoung Song; Guo-li Ming; Hongjun Song
Journal:  Mol Brain       Date:  2009-06-08       Impact factor: 4.041

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.